Developing and adapting innovative diagnostic assays for low-resource settings
My training has given me a broad range of skills and strong background in cytopathology, laboratory medicine, and public health. As a fellow at the CDC, I gained experience in developing and validating various diagnostic techniques, including immunohistochemistry, in-situ hybridization and PCR for emerging infectious diseases. I published on the histologic findings and proposed pathogenesis of Ebola Virus and Middle East respiratory syndrome coronavirus, and participated in several public surveillance projects, including an evaluation of fatal pediatric respiratory illnesses in Kenya. I am currently developing a metagenomic next generation sequencing assay for the diagnosis of infectious diseases using the Oxford Nanopore for use in low-resource settings.